THIOGENESIS THERAPEUTICS, CORP.

Press Releases Thiogenesis Therapeutics, Corp.

Equities

TTI

CA88410L1022

Market Closed - Toronto S.E. Other stock markets 08:15:14 28/06/2024 pm IST			5-day change	1st Jan Change
0.7 ^CAD	0.00%		-1.41%	-6.67%

24/05	Thiogenesis Therapeutics, Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
29/04	Thiogenesis Therapeutics, Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Press Releases

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Thiogenesis Announces Acceptance of Clinical Trial Application - Part I in the EU for MELAS	25/03	NE
Thiogenesis Announces Closing of Final Tranche in $4.5 Million Non-Brokered Private Placement	20/12	NE
Thiogenesis Announces Closing of Non-Brokered Private Placement of Common Shares and Insider Participation	18/12	NE
Thiogenesis CEO Invited to Lead a Round Table Discussion at Influential Mitochondria Symposium	04/12	NE
Thiogenesis Announces Addition of Dr. Vince Stanton Jr. to Its Scientific Advisory Board	27/11	NE
Thiogenesis Announces Non-Brokered Private Placement of Common Shares	20/11	NE

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Protect and grow your investments with the help of our experts

Securing my Investments

fermer